Testing a new drug in people with mild or moderate liver problems
Part of Digestive system clinical trials.
This study tests an experimental drug called ulonivirine to see how the body processes it in people with mild or moderate liver problems compared to healthy volunteers. It helps doctors understand if the drug is safe and how it should be dosed for people with liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older with a body mass index (BMI) between 18.5 and 40.
- You may have mild or moderate liver cirrhosis that has been stable for at least 6 months, or you may be a healthy volunteer.
- If you are taking medicines for a long-term condition, your dose must have been unchanged for at least 1 month.
- You cannot have a history of cancer, be HIV positive, or have been treated for hepatitis B or C in the last 3 months.
- You must agree to use birth control (if applicable) and not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a new oral drug (called INCB161734) is processed by the body and how safe it is in people with liver problems. It may help doctors understand the right dose for patients with liver impairment.
This trial tests a new medicine called eloralintide in people with healthy livers and in those with mild, moderate, or severe liver damage. It helps researchers learn how the liver affects the medicine in the body.
This trial tests how a new medicine, LY3537031, moves through the body and how safe it is for people with different levels of liver function. It includes people with normal livers and those with mild, moderate, or severe liver impairment.
This research study tests how a new drug called ulonivirine works with methadone in people who are stable on methadone treatment. The goal is to understand if these two medications can be safely used together without problems.
This study tests a new medicine for people with mild or moderate liver problems to see how the liver affects the drug in the body. It also includes people with normal liver function for comparison.
This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.
Hear when a new Hepatic Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.